• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

老年患者与年轻患者、射血分数保留型心力衰竭与射血分数降低型心力衰竭患者的临床表现是否存在差异?

Is the clinical presentation of chronic heart failure different in elderly versus younger patients and those with preserved versus reduced ejection fraction?

机构信息

Division of Cardiology, Internal Medicine University Department, Kantonsspital Baselland, 4101 Bruderholz, Switzerland.

Division of Cardiology, University Hospital, University of Basel, Petersgraben 4, 4031 Basel, Switzerland; Department of Cardiology, Maastricht University Medical Center, P. Debyelaan 25, PO Box 5800, 6202 AZ, Maastricht, The Netherlands.

出版信息

Eur J Intern Med. 2018 Nov;57:61-69. doi: 10.1016/j.ejim.2018.06.005. Epub 2018 Jun 13.

DOI:10.1016/j.ejim.2018.06.005
PMID:29908708
Abstract

BACKGROUND

Whether the clinical presentation and in particular prevalence of symptoms and signs of heart failure (HF) is different in elderly versus younger patients and in those with reduced (HFrEF) versus preserved (HFpEF) left ventricular ejection fraction (LVEF) is a matter of ongoing debate.

AIMS

To compare detailed clinical characteristics of these important subgroups and to develop a prediction rule for the differentiation of HFpEF and HFrEF based on clinical parameters.

METHODS

The analysis was based on the Trial of Intensified versus standard Medical therapy in Elderly patients with Congestive Heart Failure (TIME-CHF) comprising 622 patients ≥60 years with HF including the whole LVEF spectrum.

RESULTS

In the groups ≥75 years and with HFpEF typical symptoms and clinical signs of HF were more prevalent as compared to those <75 years or with HFrEF, respectively. The burden of comorbidities was higher in the older age group. HFrEF could not be differentiated from HFpEF by symptom history and clinical examination alone. However, a combination of age, presence of pulmonary rales, systolic blood pressure, cause of heart failure, osteoporosis, current smoking, NT-proBNP, haemoglobin, QRS width and heart rhythm allowed to identify HFrEF versus HFpEF with a sensitivity of 81% and specificity of 90% (c-statistics 0.91).

CONCLUSIONS

More symptoms and signs of HF were present both in the older age group and in patients with HFpEF. HFpEF versus HFrEF could be differentiated by a set of simple clinical, laboratory and ECG parameters but not by symptom history and physical examination alone.

摘要

背景

心力衰竭(HF)患者的临床表现,尤其是症状和体征的患病率,在老年患者与年轻患者、射血分数降低型心力衰竭(HFrEF)与射血分数保留型心力衰竭(HFpEF)患者之间是否存在差异,这是一个持续存在争议的问题。

目的

比较这些重要亚组的详细临床特征,并基于临床参数制定用于区分 HFpEF 和 HFrEF 的预测规则。

方法

该分析基于包含充血性心力衰竭(HF)老年患者强化与标准药物治疗试验(TIME-CHF),共纳入 622 名年龄≥60 岁且 LVEF 谱完整的 HF 患者。

结果

与年龄<75 岁或 HFrEF 患者相比,≥75 岁患者和 HFpEF 患者HF 的典型症状和体征更为常见。年龄较大的患者合并症负担更高。仅通过症状史和临床检查无法区分 HFrEF 和 HFpEF。然而,年龄、肺部啰音、收缩压、心力衰竭病因、骨质疏松症、当前吸烟、NT-proBNP、血红蛋白、QRS 宽度和心律的综合组合可识别 HFrEF 与 HFpEF,其敏感性为 81%,特异性为 90%(C 统计量 0.91)。

结论

在老年患者和 HFpEF 患者中,HF 的症状和体征更为常见。HFpEF 与 HFrEF 可通过一组简单的临床、实验室和心电图参数来区分,但不能仅通过症状史和体格检查来区分。

相似文献

1
Is the clinical presentation of chronic heart failure different in elderly versus younger patients and those with preserved versus reduced ejection fraction?老年患者与年轻患者、射血分数保留型心力衰竭与射血分数降低型心力衰竭患者的临床表现是否存在差异?
Eur J Intern Med. 2018 Nov;57:61-69. doi: 10.1016/j.ejim.2018.06.005. Epub 2018 Jun 13.
2
Heart failure with mid-range ejection fraction: a distinct clinical entity? Insights from the Trial of Intensified versus standard Medical therapy in Elderly patients with Congestive Heart Failure (TIME-CHF).射血分数中间值的心衰:一种明确的临床实体?来自强化与标准药物治疗充血性心力衰竭老年患者的试验(TIME-CHF)的见解。
Eur J Heart Fail. 2017 Dec;19(12):1586-1596. doi: 10.1002/ejhf.798. Epub 2017 Mar 15.
3
[Contemporary epidemiology and treatment of hospitalized heart failure patients in real clinical practice in China].[中国实际临床实践中住院心力衰竭患者的当代流行病学与治疗]
Zhonghua Xin Xue Guan Bing Za Zhi. 2019 Nov 24;47(11):865-874. doi: 10.3760/cma.j.issn.0253-3758.2019.11.004.
4
N-terminal pro brain natriuretic peptide-guided management in patients with heart failure and preserved ejection fraction: findings from the Trial of Intensified versus standard medical therapy in elderly patients with congestive heart failure (TIME-CHF).N 末端脑利钠肽前体指导心力衰竭伴射血分数保留患者的管理:充血性心力衰竭老年患者强化与标准药物治疗试验(TIME-CHF)的结果。
Eur J Heart Fail. 2013 Oct;15(10):1148-56. doi: 10.1093/eurjhf/hft076. Epub 2013 May 8.
5
Left atrial volume and left ventricular mass indices in heart failure with preserved and reduced ejection fraction.左心房容积和左心室质量指数在射血分数保留和降低的心力衰竭中的变化。
ESC Heart Fail. 2021 Aug;8(4):2458-2466. doi: 10.1002/ehf2.13366. Epub 2021 Jun 4.
6
Acute heart failure with mid-range left ventricular ejection fraction: clinical profile, in-hospital management, and short-term outcome.左心室射血分数中等范围的急性心力衰竭:临床特征、住院治疗及短期预后
Clin Res Cardiol. 2017 May;106(5):359-368. doi: 10.1007/s00392-016-1063-0. Epub 2016 Dec 20.
7
Circulating biomarkers of distinct pathophysiological pathways in heart failure with preserved vs. reduced left ventricular ejection fraction.心力衰竭保留和降低左心室射血分数患者不同病理生理途径的循环生物标志物。
Eur J Heart Fail. 2015 Oct;17(10):1006-14. doi: 10.1002/ejhf.414. Epub 2015 Oct 16.
8
Contribution of cardiac and extra-cardiac disease burden to risk of cardiovascular outcomes varies by ejection fraction in heart failure.心力衰竭患者的心脏和心脏外疾病负担对心血管结局风险的影响因射血分数而异。
Eur J Heart Fail. 2018 Mar;20(3):504-510. doi: 10.1002/ejhf.1073. Epub 2017 Nov 30.
9
Heart Failure and Midrange Ejection Fraction: Implications of Recovered Ejection Fraction for Exercise Tolerance and Outcomes.心力衰竭与中等射血分数:射血分数恢复对运动耐量和预后的影响
Circ Heart Fail. 2016 Apr;9(4):e002826. doi: 10.1161/CIRCHEARTFAILURE.115.002826.
10
Epidemiology and one-year outcomes in patients with chronic heart failure and preserved, mid-range and reduced ejection fraction: an analysis of the ESC Heart Failure Long-Term Registry.慢性心力衰竭伴射血分数保留、中间范围和降低患者的流行病学和一年结局:ESC 心力衰竭长期注册研究分析。
Eur J Heart Fail. 2017 Dec;19(12):1574-1585. doi: 10.1002/ejhf.813. Epub 2017 Apr 6.

引用本文的文献

1
Non-Invasive Hemodynamic Assessment of Heart Failure With Preserved Ejection Fraction.射血分数保留的心力衰竭的非侵入性血流动力学评估
Korean Circ J. 2025 Mar;55(3):165-184. doi: 10.4070/kcj.2024.0370.
2
Reviewing the Modern Therapeutical Options and the Outcomes of Sacubitril/Valsartan in Heart Failure.探讨沙库巴曲缬沙坦在心力衰竭中的现代治疗选择和结局。
Int J Mol Sci. 2022 Sep 26;23(19):11336. doi: 10.3390/ijms231911336.
3
Background and Design of the Biological and Physiological Mechanisms of Symptom Clusters in Heart Failure (BIOMES-HF) Study.
背景与心力衰竭症状群的生物学和生理学机制(BIOMES-HF)研究设计。
J Card Fail. 2022 Jun;28(6):973-981. doi: 10.1016/j.cardfail.2022.01.003. Epub 2022 Jan 16.
4
The Anti-Inflammatory and Antioxidant Properties of n-3 PUFAs: Their Role in Cardiovascular Protection.n-3多不饱和脂肪酸的抗炎和抗氧化特性:它们在心血管保护中的作用。
Biomedicines. 2020 Aug 25;8(9):306. doi: 10.3390/biomedicines8090306.
5
Symptom Perception and Influencing Factors in Chinese Patients with Heart Failure: A Preliminary Exploration.中国心力衰竭患者的症状感知及影响因素:初步探索
Int J Environ Res Public Health. 2020 Apr 14;17(8):2692. doi: 10.3390/ijerph17082692.
6
Heart Failure with Reduced Ejection Fraction (HFrEF) and Preserved Ejection Fraction (HFpEF): The Diagnostic Value of Circulating MicroRNAs.射血分数降低的心力衰竭(HFrEF)和射血分数保留的心力衰竭(HFpEF):循环 microRNAs 的诊断价值。
Cells. 2019 Dec 16;8(12):1651. doi: 10.3390/cells8121651.